Strattera 40 mg kapsler, hårde Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 40 mg kapsler, hårde

paranova danmark a/s - atomoxetinhydrochlorid - kapsler, hårde - 40 mg

Strattera 60 mg kapsler, hårde Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 60 mg kapsler, hårde

paranova danmark a/s - atomoxetinhydrochlorid - kapsler, hårde - 60 mg

Strattera 80 mg kapsler, hårde Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 80 mg kapsler, hårde

paranova danmark a/s - atomoxetinhydrochlorid - kapsler, hårde - 80 mg

Striverdi Respimat 2,5 mikrogram inhalationsvæske, opløsning Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

striverdi respimat 2,5 mikrogram inhalationsvæske, opløsning

orifarm a/s - olodaterol - inhalationsvæske, opløsning - 2,5 mikrogram

Strattera 4 mg/ml oral opløsning Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

strattera 4 mg/ml oral opløsning

eli lilly danmark a/s - atomoxetinhydrochlorid - oral opløsning - 4 mg/ml

Xoterna Breezhaler Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

xoterna breezhaler

novartis europharm limited - indacaterol, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - adrenergica i kombinationer med antikolinergika inkl. tredobbelte kombination med kortikosteroider - xoterna breezhaler er indiceret som bronkodilaterende vedligeholdelsesbehandling at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (kol).

Ultibro Breezhaler Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

ultibro breezhaler

novartis europharm limited - indacaterol, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - adrenergica i kombinationer med antikolinergika inkl. tredobbelte kombination med kortikosteroider, medicin til obstruktiv sygdomme, - ultibro breezhaler er indiceret som bronkodilaterende vedligeholdelsesbehandling at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (kol).

Enerzair Breezhaler Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

enerzair breezhaler

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Bemrist Breezhaler Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

bemrist breezhaler

novartis europharm limited  - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Atectura Breezhaler Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

atectura breezhaler

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - medicin for obstruktiv sygdomme, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.